Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

Stopped This study was closed earlier than planned because targeted participant recruitment is not smooth.

Conditions

• Liver Disease

Interventions

• DRUG: Preoperative Gabexate Mesilate group
• DRUG: Intraoperative Gabexate Mesilate group
• DRUG: hepatectomy with dextrose water

Sponsor

Yonsei University